How to Buy Kalvista Pharmaceuticals Stock

Kalvista Pharmaceuticals Inc

KalVista Pharmaceuticals, Inc. , a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs.

Kalvista Pharmaceuticals stock last closed at $26.77, up 0.04% from the previous day, and has increased 121.79% in one year. It has overperformed other stocks in the Biotechnology industry by 1.99 percentage points. Kalvista Pharmaceuticals stock is currently +172.33% from its 52-week low of $9.83, and -0.3% from its 52-week high of $26.85.

As of May 19, 2026, there are 53.24M shares of KALV outstanding. The market value of KALV is $1.43B. In the last 24 hours, 7.94M KALV shares were traded.

How to Buy Kalvista Pharmaceuticals Stock

Not sure how to invest in Kalvista Pharmaceuticals stock? Here's how.

  1. Decide where to buy Kalvista Pharmaceuticals stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you figure out where to buy Kalvista Pharmaceuticals stock.
  2. Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Deposit funds into your brokerage account: Choose your payment method and add your details.
  4. Research Kalvista Pharmaceuticals stock: The Kalvista Pharmaceuticals ticker symbol is KALV. Is Kalvista Pharmaceuticals stock a good investment? Should you buy shares of KALV? How do KALV's underlying business fundamentals look? Do top analysts think Kalvista Pharmaceuticals is a good buy? Why has KALV's stock price moved recently? (Hint: Our stock market research website can help you figure out if KALV is a good stock to buy).
  5. Execute your KALV purchase: Decide if you will purchase KALV shares at the current market price or use a limit order to purchase KALV shares at a particular price.
  6. Track your KALV position: Create a watchlist to important updates regarding your position in Kalvista Pharmaceuticals shares.

Step 1: Decide where to buy Kalvista Pharmaceuticals stock

You need a brokerage account in order to access the NASDAQ market and buy KALV shares.

A brokerage account is an investment account that allows you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

In our opinion, eToro is the best place to buy stocks. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to global markets: From Tech to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
  • Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create your brokerage account

Now that you've picked the best brokerage, it's time to fill out some personal info so you are able to invest in KALV stock today.

How to Open a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal info to open your new trading account.
  1. Submit your information by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your brokerage account

Now that you have finished signing up on the best stock app, your next step is to transfer the money for your investment:

Check out the walkthrough below for more details transferring money into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Kalvista Pharmaceuticals stock

Once you have figured out the best place to buy Kalvista Pharmaceuticals stock, it's very important to analyze their stock prior to buying, so you truly understand the risk as well as the upside.

Kalvista Pharmaceuticals quick stats

KALV Price
$26.77
1w %
0.15%
1y %
121.79%
5y %
4.98%
P/E
N/A
P/B
-72.52x
P/S
N/A
PEG
N/A
Revenue
N/A
Earnings
N/A
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$1.43B
Next Earnings
N/A
Next Dividend
N/A

Fundamentals of KALV

WallStreetZen was designed to help everyday investors perform better fundamental analysis in less time.

You can see all of the due diligence checks on KALV's stock page.

Is KALV stock overvalued?

Analysts use many financial metrics, analyses, models, and charts to gauge KALV's intrinsic value.

You can do additional valuation analysis on KALV's stock here.

KALV Financial Overview

Pros:

  • There are more short-term assets than short-term liabilities on the KALV balance sheet.
  • There are more short-term assets than long-term liabilities on the KALV balance sheet.

Cons:

  • KALV debt to equity ratio of -17.74 is negative.
  • Total KALV debt is still negative.

Is it a good time to buy KALV stock, according to analysts?

Out of 5 sell side analysts who give ratings on KALV, the consensus analyst rating on KALV is a Buy

It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.

You can dig deeper into what analysts are projecting on the Kalvista Pharmaceuticals stock forecast page.

KALV Technical Indicators

SMA10
26.74
SMA20
24.87
SMA50
21.15
SMA100
18.38
SMA200
15.79
MACD
1.82
MACD Signal
1.93
MACD Histogram
-0.11
RSI
74.97
Stochastic %K
73.73
Stochastic %D
86.04
StochRSI %K
44.79
StochRSI %D
71.14

Are KALV executives and large shareholders buying or selling the stock?

Over the past year, executives and large shareholders at KALV have sold more shares than they have bought.

Paul K. Audhya, CHIEF MEDICAL OFFICER of KALV, was the latest KALV insider to sell. They sold $27,616.32 worth of KALV shares on May 18, 2026.

Get more info about who owns KALV shares here.

Does KALV stock generate passive income?

No, Kalvista Pharmaceuticals doesn't provide an income stream by paying out dividends.

KALV Social Trading Data

One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to see what other community members have to say.

Step 5: Execute your KALV purchase

There are two primary options:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are usually the best for newer investors.
  • Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
    If you want to make sure you're buying or selling at a particular price, place a limit order.

Click the Open button and your broker will place the order.

If you want additional help with investing in stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Track your KALV position

Now that you own some shares in KALV, you'll want to keep up with your company.

Add KALV to a watchlist to keep tabs on your KALV stock.

KALV Feed

How to Buy Stock in Kalvista Pharmaceuticals

To summarize, here are the 6 steps you need to take to buy Kalvista Pharmaceuticals stock right now:

  1. Decide where to buy Kalvista Pharmaceuticals stock
  2. Create your brokerage account
  3. Deposit funds into your brokerage account
  4. Research Kalvista Pharmaceuticals stock
  5. Execute your KALV purchase
  6. Track your KALV position

If you need a brokerage, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to watch your investment in Kalvista Pharmaceuticals, click the button below.

NASDAQ: KALV
$26.77+0.01 (+0.04%)
Updated May 19, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: KALV
$26.77+0.01 (+0.04%)
Updated May 19, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Kalvista Pharmaceuticals share?

As of May 19, 2026, it costs $26.77 to buy one share of Kalvista Pharmaceuticals stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.374 shares of KALV.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Kalvista Pharmaceuticals stock?

According to 5 Wall Street analysts who monitor Kalvista Pharmaceuticals, their consensus recommendation is to buy Kalvista Pharmaceuticals stock.

What is the best way to buy Kalvista Pharmaceuticals stock?

One way to place an order for Kalvista Pharmaceuticals stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.